McKesson and Clayton Dubilier & Rice Agree to Acquire Option Care Health in $5.8 Billion Deal
Option Care Health has agreed to be acquired by McKesson and Clayton Dubilier & Rice for $32.05 per share in a transaction valued at $5.8 billion. The stock surged 32.88% on the news, reaching $31.055 as of mid-morning trading on Tuesday. Technical indicators show the daily RSI has climbed to 83.76, indicating overbought conditions following the significant price jump.
McKesson Corporation and private equity firm Clayton Dubilier & Rice have committed to purchasing Option Care Health, a home infusion and healthcare services provider, at $32.05 per share. The transaction represents a significant consolidation within the healthcare services sector, valued at approximately $5.8 billion. Investor enthusiasm preceded the official announcement, with shares climbing 22% in after-hours trading following earlier reports of advanced negotiations.
The dramatic price movement reflects the gap between the stock's pre-announcement trading levels and the agreed acquisition price, with technical indicators reaching extreme readings across multiple timeframes. The stock's velocity and the scale of the premium suggest limited arbitrage risk perceived by market participants regarding deal completion.
This acquisition could reshape the home infusion therapy landscape by combining McKesson's pharmaceutical distribution infrastructure with a specialized care provider, potentially affecting patient access and service delivery models. Healthcare providers, competitors, and patients reliant on infusion services may experience operational changes or consolidation within their service networks. The deal also reflects private equity's continued interest in healthcare services, which could influence pricing dynamics and investment availability for similar operators in the sector.